Renaissance Technologies
BNGO icon

Renaissance Technologies’s Bionano Genomics BNGO Stock Holding History

Renaissance Technologies’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57K Buy
48,700
+11,700
+32% +$15K ﹤0.01% 3100
2025
Q4 		$56.6K Buy
+37,000
New +$64K ﹤0.01% 3080
2025
Q1 		– Sell
-2,638
Closed -$45.7K – 3478
2024
Q4 		$45.7K Buy
+2,638
New +$45.1K ﹤0.01% 3405
2024
Q1 		– Sell
-8,571
Closed -$972K – 3716
2023
Q4 		$972K Buy
+8,571
New +$895K ﹤0.01% 2425
2022
Q4 		– Sell
-2,349
Closed -$2.58M – 4124
2022
Q3 		$2.58M Sell
2,349
-3,747
-61% -$4.95M ﹤0.01% 1861
2022
Q2 		$5.05M Buy
6,096
+5,915
+3,268% +$6.09M 0.01% 1550
2022
Q1 		$281K Buy
+181
New +$244K ﹤0.01% 3497
2021
Q2 		– Sell
-15,811
Closed -$76.7M – 3467
2021
Q1 		$76.7M Buy
+15,811
New +$89.1M 0.1% 221

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Renaissance Technologies's BNGO Position: Q1 2026 in Review

Renaissance Technologies increased its Bionano Genomics (BNGO) stake by 32% in Q1 2026, buying an estimated $15K and bringing the position to 48,700 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #3100.

Renaissance Technologies first reported a position in BNGO in Q1 2021 and has held it in 8 quarters since. The position peaked at $76.7M in Q1 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Renaissance Technologies held 48,700 shares of Bionano Genomics worth $57K as of Q1 2026.
  • Renaissance Technologies bought 11,700 Bionano Genomics shares in Q1 2026, an estimated $15K.
  • Bionano Genomics made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3100 holding.
  • Renaissance Technologies first reported a position in Bionano Genomics in Q1 2021 and has held it in 8 quarters since.
  • Renaissance Technologies's Bionano Genomics position peaked at $76.7M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.